We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
ADVFN Financial News : Breaking financial news, market insights, commentary & economic analysis from the world stock markets.
U.S. Crude Oil Stocks Fall More Than Expected in Week Ended Jan. 19By Anthony Harrup U.S. crude oil inventories fell more than expected last week as production and refinery runs dropped amid severe winter weather across much of the U.S., according to data released Wednesday by the U.S. Energy Information Administration... |
ASML Holding Up Nearly 9%, on Track for Highest Close Since November 2021 -- Data..ASML Holding NV ADR ( ASML ) is currently at $848.22, up $69.83 or 8.97% --Would be highest close since Nov. 19, 2021, when it closed at $857.17 --On pace for largest percent increase since Nov. 10, 2022, when it rose 14.57% --Currently up six consecutive... |
News Highlights: Top Company News of the Day - Wednesday at 11 AM ETKimberly-Clark Stock Falls After Earnings. At Least There Was Another Dividend Hike. Consumer-products company Kimberly-Clark lifts its dividend once again, but investors are focused on the numbers that missed estimates. Chipotle to Offer New Benefits to... |
Capricor Therapeutics Shares Rise 7% After Collaboration for Covid-19 VaccineBy Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the prevention of SARS-CoV-2 has been selected to be part of Project NextGen. The stock hit its 52-week low... |
Haleon Recalls Two Versions of Robitussin Due to Microbial ContaminationBy Denny Jacob Haleon voluntarily recalled two versions of cough medicine Robitussin due to a microbial contamination. The personal healthcare products provider said the recall affects eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF... |
Heron Therapeutics Shares Rise 15% After FDA Approves Expanded Use of ZynrelefBy Chris Wack Heron Therapeutics shares were up 15% to $2.53 after the U.S. Food and Drug Administration approved its supplemental new drug application for Zynrelef extended-release solution. The biotechnology company said the approval expands the... |
Theratechnologies Shares Sink at Open After FDA Rejects Newer Tesamorelin..By Robb M. Stewart and Colin Kellaher Theratechnologies shares fell sharply at the opening bell after the Food and Drug Administration denied approval for a newer formulation of tesamorelin that the Canadian biopharmaceutical company proposed as a... |
U.S. Business Activity Picks Up Pace at Start of Year, PMIs ShowBy Joshua Kirby U.S. business activity grew more quickly in January thanks to a strong services sector and recovery in manufacturing, a purchasing managers' survey showed Wednesday. The S&P Global Flash U.S. Composite PMI--which gauges activity in... |
Netflix Up Nearly 14%, on Track for Highest Close Since January 2022 -- Data TalkNetflix, Inc. (NFLX) is currently at $560.32, up $68.13 or 13.84% --Would be highest close since Jan. 5, 2022, when it closed at $567.52 --On pace for largest percent increase since Oct. 19, 2023, when it rose 16.05% --Currently up four of the past five... |
Enel Solar Gigafactory Secures $608 Million Financing to Expand Production CapacityBy Nina Kienle Enel's Italian solar gigafactory secured a 560 million-euro ($607.9 million) financing package from the European Investment Bank and a pool of Italian banks to expand production capacity. Enel Green Power's 3Sun, located in... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
